4 Midcap Five-Year Winner Fast Profit and Revenue Growth Stocks to Watch for Future Multibagger Potential: Dixon, Radico Khaitan, Fortis Healthcare and KEI Industries
- November 12, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Dixon Rs 12,896. Radico Khaitan Rs 4,440.30. Fortis Healthcare Rs 772. KEI Industries Rs 4,006.40. Market caps from Rs 40,109 crore to Rs 87,160 crore. Data as of 11 Nov 2026.
Quick Answer
Dixon, Radico Khaitan, Fortis Healthcare and KEI Industries are the 4 picks in this five-year winner fast profit and revenue growth stocks watchlist, with market caps between Rs 40,109 crore and Rs 87,160 crore. Dixon stands out for the highest return on equity at 30.76%, while Radico Khaitan offers 24.84% revenue growth in FY26. PE ratios run from 40.24 to 88.71, so compare each one with its industry PE before investing. All figures are as of 11 November 2026.
Five-year winner fast profit and revenue growth stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Dixon, Radico Khaitan, Fortis Healthcare and KEI Industries meet that test, with market caps from Rs 40,109 crore to Rs 87,160 crore and Dixon offering the highest return on equity at 30.76%. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a five-year share price return of at least 100 per cent, FY26 net profit growth of at least 20 per cent and FY26 revenue growth of at least 15 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a five-year share price return of at least 100 per cent, FY26 net profit growth of at least 20 per cent and FY26 revenue growth of at least 15 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening five-year winner fast profit and revenue growth stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 11 November 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Five-Year Winner Fast Profit and Revenue Growth Stocks and Why Do They Attract Multibagger Interest?
Five-year winner fast profit and revenue growth stocks are shares of mid sized companies whose share price has at least doubled over five years, whose net profit grew by twenty per cent or more in FY26 and whose sales grew by fifteen per cent or more. The four here cover electronics manufacturing, hospitals, spirits and cables.
A doubled share price shows that the market has rewarded the business over a long period, and fast growth in both profit and sales shows that the business is still expanding broadly. Within five-year winner fast profit and revenue growth stocks, the four companies show rising profit. For five-year winner fast profit and revenue growth stocks, both FY26 and the latest quarter showed growth. Whichever way you read five-year winner fast profit and revenue growth stocks, the common thread is rising profit backed by complete financial data. For five-year winner fast profit and revenue growth stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of five-year winner fast profit and revenue growth stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for five-year winner fast profit and revenue growth stocks before you decide.
Five-Year Winner Fast Profit and Revenue Growth Stocks at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 11 November 2026. KEI Industries has the lowest PE of the group at 40.24, while Dixon posts the highest return on equity at 30.76%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Dixon Technologies | 12,896 | 87,160 | 41.87 | 45.19 | 30.76% | 0.21 | 9,600.00 to 17,299.00 |
| Radico Khaitan | 4,440.30 | 62,417 | 88.71 | 54.95 | 18.23% | 0.15 | 2,500.00 to 4,747.00 |
| Fortis Healthcare | 772 | 58,765 | 54.89 | 60.75 | 10.53% | 0.35 | 565.00 to 790.65 |
| KEI Industries | 4,006.40 | 40,109 | 40.24 | 49.96 | 13.78% | 0.04 | 3,725.00 to 5,899.00 |
Dixon: 71.44% Profit CAGR Since FY22
Dixon Technologies is an electronics manufacturing services company that makes televisions, phones, appliances and lighting for brands. It reported FY26 revenue of Rs 49,585.84 crore, up 27.53% year on year, and net profit of Rs 1,644.25 crore, up 33.40%. Net profit has compounded at 71.44% a year since FY22, while revenue has grown 46.72% a year. Operating margin was 3.95% in FY26. The debt-to-equity ratio is 0.21.
In the June 2026 quarter, revenue rose 25.23% to Rs 16,075.95 crore and net profit grew 156.35% to Rs 717.83 crore. The share price has gained 115.16% over five years. The stock trades at a PE of 41.87 against an industry PE of 45.19, below the sector average, with a return on equity of 30.76%.
Radico Khaitan: 24.88% Profit CAGR Since FY22
Radico Khaitan makes Indian-made foreign liquor and premium spirits, with brands including Magic Moments, 8PM and Rampur Single Malt. It reported FY26 revenue of Rs 6,062.27 crore, up 24.84% year on year, and net profit of Rs 604.48 crore, up 74.90%. Net profit has compounded at 24.88% a year since FY22, while revenue has grown 20.50% a year. Operating margin was 4.88% in FY26. The debt-to-equity ratio is 0.15, which keeps interest costs low.
The stock trades at a PE of 88.71 against an industry PE of 54.95, with a return on equity of 18.23%. In the June 2026 quarter, revenue rose 10.44% to Rs 5,869.46 crore and net profit grew 75.91% to Rs 229.60 crore. The share price has gained 313.35% over five years and 56.69% over the past year. Domestic institutions raised their holding from 25.47% in September 2025 to 27.17% in September 2026.
Fortis Healthcare: Five-Year Gain of 243.69%
Fortis Healthcare operates a chain of hospitals and diagnostic centres across India. It reported FY26 revenue of Rs 9,178.50 crore, up 16.93% year on year, and net profit of Rs 1,064.19 crore, up 31.48%. Net profit has compounded at 7.73% a year since FY22, while revenue has grown 12.43% a year. Operating margin was 22.41% in FY26. The debt-to-equity ratio is 0.35.
In the June 2026 quarter, revenue rose 17.29% to Rs 2,559.50 crore and net profit grew 2.26% to Rs 272.80 crore. The share price has gained 243.69% over five years. Domestic institutions raised their holding from 29.79% in June 2025 to 32.23% in June 2026. The stock trades at a PE of 54.89 against an industry PE of 60.75, below the sector average.
KEI Industries: 25.01% Profit CAGR Since FY22
KEI Industries makes power, control and instrumentation cables, including extra-high-voltage cables, and house wires. It reported FY26 revenue of Rs 11,906.32 crore, up 21.40% year on year, and net profit of Rs 918.43 crore, up 31.88%. Net profit has compounded at 25.01% a year since FY22, while revenue has grown 20.00% a year. Operating margin was 11.81% in FY26. The debt-to-equity ratio is 0.04, which keeps interest costs low.
The stock trades at a PE of 40.24 against an industry PE of 49.96, below the sector average, with a return on equity of 13.78%. In the June 2026 quarter, revenue rose 21.86% to Rs 3,204.91 crore and net profit grew 40.05% to Rs 274.14 crore. The share price has gained 374.59% over five years. Foreign investors raised their holding from 26.59% in June 2025 to 27.32% in June 2026.
Five-Year Winner Fast Profit and Revenue Growth Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these five-year winner fast profit and revenue growth stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | 4-Year Net Profit CAGR | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| Dixon | 49,585.84 | 1,644.25 | 27.53% | 46.72% | 71.44% | 6.43% |
| Radico Khaitan | 6,062.27 | 604.48 | 24.84% | 20.50% | 24.88% | 6.10% |
| Fortis Healthcare | 9,178.50 | 1,064.19 | 16.93% | 12.43% | 7.73% | 22.22% |
| KEI Industries | 11,906.32 | 918.43 | 21.40% | 20.00% | 25.01% | 13.04% |
Institutional Holding in Dixon, Radico Khaitan, Fortis Healthcare and KEI Industries
Institutional holding shows who is backing these five-year winner fast profit and revenue growth stocks alongside the promoter. The table uses the latest reported quarter for each. Fortis Healthcare has the deepest institutional backing, with FII and DII together holding 57.43% as of June 2026. Domestic institutions increased their holding over the past year in Radico Khaitan (from 25.47% to 27.17%) and Fortis Healthcare (from 29.79% to 32.23%). Keeping an eye on the Nifty Midcap 100 alongside this list shows whether these shares are moving with the wider market.
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Dixon | 28.50% | 18.96% | 28.71% | 23.83% | September 2026 |
| Radico Khaitan | 40.17% | 19.43% | 27.17% | 13.23% | September 2026 |
| Fortis Healthcare | 31.17% | 25.20% | 32.23% | 11.40% | June 2026 |
| KEI Industries | 35.00% | 27.32% | 25.90% | 11.78% | June 2026 |
Risks to Weigh in Five-Year Winner Fast Profit and Revenue Growth Stocks
Being careful with five-year winner fast profit and revenue growth stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Radico Khaitan trades at a PE of 88.71 against an industry PE of 54.95, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Five-Year Winner Fast Profit and Revenue Growth Stocks
Picking from five-year winner fast profit and revenue growth stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (45.19 to 60.75) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Dixon, Radico Khaitan, Fortis Healthcare and KEI Industries live prices.
Conclusion
Among five-year winner fast profit and revenue growth stocks, Dixon stands out for the highest return on equity at 30.76%, Radico Khaitan for 24.84% revenue growth in FY26, Fortis Healthcare for 16.93% revenue growth in FY26 and KEI Industries for the biggest five-year price gain at 374.59%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing five-year winner fast profit and revenue growth stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Five-Year Winner Fast Profit and Revenue Growth Stocks to Watch
Which are the best five-year winner fast profit and revenue growth stocks to watch for multibagger potential?
Ans. Dixon, Radico Khaitan, Fortis Healthcare and KEI Industries are the 4 names this list highlights, with market caps of Rs 87,160 crore, Rs 62,417 crore, Rs 58,765 crore and Rs 40,109 crore respectively. Dixon is notable for the highest return on equity at 30.76%. Radico Khaitan stands out for 24.84% revenue growth in FY26. Fortis Healthcare offers 16.93% revenue growth in FY26. KEI Industries brings the biggest five-year price gain at 374.59%. These are watchlist names for five-year winner fast profit and revenue growth stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Dixon a good stock for long-term investors?
Ans. Dixon has a return on equity of 30.76%, a PE of 41.87 against an industry PE of 45.19 and a market cap of Rs 87,160 crore. Net profit has compounded at 71.44% a year since FY22, and FY26 revenue rose 27.53% while June 2026 quarter net profit grew 156.35%. Long-term returns in five-year winner fast profit and revenue growth stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can KEI Industries become a multibagger from here?
Ans. KEI Industries has already gained 374.59% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in five-year winner fast profit and revenue growth stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 25.01% a year since FY22, and FY26 revenue rose 21.40%. At a PE of 40.24 against an industry PE of 49.96, valuation should be checked against that growth before investing.
What is the market cap of Dixon, Radico Khaitan, Fortis Healthcare and KEI Industries?
Ans. As of 11 November 2026, Dixon has a market cap of Rs 87,160 crore, Radico Khaitan has a market cap of Rs 62,417 crore, Fortis Healthcare has a market cap of Rs 58,765 crore and KEI Industries has a market cap of Rs 40,109 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on five-year winner fast profit and revenue growth stocks.
What are the risks of investing in five-year winner fast profit and revenue growth stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Radico Khaitan trades at a PE of 88.71 against an industry PE of 54.95, so earnings growth needs to hold up.
Why is Radico Khaitan trading at a PE of 88.71?
Ans. Radico Khaitan’s PE of 88.71 compares with an industry PE of 54.95. The market is paying a premium for a return on equity of 18.23%, profit growth of 24.88% a year since FY22 and latest-quarter profit growth of 75.91%, which also means the stock is more sensitive if growth slows. Investors in five-year winner fast profit and revenue growth stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Dixon, Radico Khaitan, Fortis Healthcare and KEI Industries?
Ans. As of the latest reported quarter, FII and DII together hold 47.67% of Dixon (18.96% and 28.71%), 46.60% of Radico Khaitan (19.43% and 27.17%), 57.43% of Fortis Healthcare (25.20% and 32.23%) and 53.22% of KEI Industries (27.32% and 25.90%). Rising institutional holding is a useful signal in five-year winner fast profit and revenue growth stocks, though it should be read with earnings trends rather than on its own.
